Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Article Dans Anglais | IMSEAR | ID: sea-135864

Résumé

Background & objectives: Rise in prevalence of multi-drug resistance (MDR) in tubercle bacilli is a serious cause of concern. As mutations with two house keeping genes rpoB and katG are associated with resistance to two important anti-tubercular drugs rifampicin and isoniazid respectively, there is a need to understand the growth kinetics of organisms with such mutated genes in experimental animals. This study was undertaken to study the growth kinetics of susceptible as well multi-drug resistance Mycobacterium tuberculosis isolates in mice. Methods: Two MDR (having mutations in rpoB and catG) and two drug susceptible isolates of M. tuberculosis along with H37Rv were grown in mice after aerogenic infection. Results: The MDR isolates grew slowly up to 3 wk though the growth was significantly different from sensitive strains. However, after 3 wk, the growth in sensitive as well MDR strains was similar, suggesting that even the mutations in the MDR strains did not have any impact on the growth kinetics. Interpretation & conclusions: The effect of mutations in other parts of these genes need to be studied. Retention of property of MDR strains to establish infection after aerogenic infection has epidemiological significance in terms of the transmission of MDR tuberculosis.


Sujets)
Animaux , Antituberculeux/usage thérapeutique , Multirésistance bactérienne aux médicaments , Tuberculose ultrarésistante aux médicaments/traitement médicamenteux , Tuberculose ultrarésistante aux médicaments/épidémiologie , Tuberculose ultrarésistante aux médicaments/physiopathologie , Humains , Poumon/microbiologie , Poumon/anatomopathologie , Souris , Souris de lignée BALB C , Tests de sensibilité microbienne , Mycobacterium tuberculosis/génétique , Mycobacterium tuberculosis/pathogénicité , Mycobacterium tuberculosis/physiologie , Rifampicine/usage thérapeutique , Tuberculose multirésistante/traitement médicamenteux , Tuberculose multirésistante/épidémiologie , Tuberculose multirésistante/physiopathologie
SÉLECTION CITATIONS
Détails de la recherche